Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024)

Oculis Holding AG (OCS) recorded quarterly Cash from Investing Activities of -$19.7 million in Q2 2024, down 738.58% quarter-over-quarter from -$2.3 million in Q1 2024.

Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024) Analysis & Trends

Oculis Holding AG's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$19.7 million for Q2 2024.

  • In Q2 2024, Cash from Investing Activities changed N/A year-over-year to -$19.7 million; the TTM figure through Jun 2024 stood at -$464875.5 (changed N/A YoY), while the FY2025 annual figure was -$76.2 million, down 315.26% from the prior year.
  • Cash from Investing Activities was -$19.7 million for Q2 2024 at Oculis Holding AG, down from -$2.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $25.9 million in Q4 2023 to a low of -$19.7 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$427938.7 across 3 years, with a median of -$2.0 million in 2024.
  • Biggest YoY gain for Cash from Investing Activities was 1744.57% in 2023; the steepest drop was 714.06% in 2023.
  • A 3-year view of Cash from Investing Activities shows it stood at -$1.6 million in 2022, then jumped by 1744.57% to $25.9 million in 2023, then tumbled by 176.04% to -$19.7 million in 2024.
  • The last three Cash from Investing Activities figures came in at -$19.7 million (Q2 2024), -$2.3 million (Q1 2024), and $25.9 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.89 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -431.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 579,519.10
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -19.67 Mn
Jun 30, 2024 -19.67 Mn
Mar 31, 2024 -2.35 Mn
Mar 31, 2024 -2.35 Mn
Dec 31, 2023 25.86 Mn
Dec 31, 2023 25.86 Mn
Sep 30, 2023 -4.32 Mn
Sep 30, 2023 -4.32 Mn
Dec 31, 2022 -1.57 Mn
Dec 31, 2022 -1.57 Mn
Sep 30, 2022 -530,153.80
Sep 30, 2022 -530,153.80